CENPJ, centromere protein J, 55835

N. diseases: 150; N. variants: 24
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.040 Biomarker disease BEFREE Patients with HF and OSA were randomized to the following study groups: control, exercise, CPAP, and exercise + CPAP. 30213463 2018
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.040 Biomarker disease BEFREE Each 1-hour increase in CPAP use was associated with a 14% decreased risk of 30-day HF readmission among PLHIV. 29534158 2018
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.040 Biomarker disease BEFREE In patients with HF and with CSA unsuppressed with CPAP, newer ASV use has been associated with significant CSA improvement; in addition, several studies have reported efficacy of ASV in the treatment of underlying cardiac dysfunction in HF patients with CSA. 29884256 2018
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.040 Biomarker disease BEFREE The most common indications for ASV were CSA in heart failure (41%) in the cardiac setting and treatment emergent CSA (80%) diagnosed after an appropriate period on CPAP in the respirology setting. 28417254 2017